Reconstitution of TGFBR2 in HCT116 colorectal cancer cells causes increased LFNG expression and enhanced N-acetyl-d-glucosamine incorporation into Notch1

Cellular Signalling

Volumn 28, Issue 8, 2016, Pages 1105-1113

  Lee, Jennifer ^a,b   Katzenmaier, Eva Maria ^a,b   Kopitz, Jürgen ^a,b   Gebert, Johannes ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Colorectal cancer; Glycosylation; LFNG; Microsatellite instability; Notch1; TGFBR2

Indexed keywords

GLYCOSYLTRANSFERASE; N ACETYLGLUCOSAMINE; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PROTEIN LFNG; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; LFNG PROTEIN, HUMAN; NOTCH RECEPTOR; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HCT116 CELL LINE; HES1 GENE; JUNB GENE; LFNG GENE; MICROSATELLITE INSTABILITY; PLATELET DERIVED GROWTH FACTOR B GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL CLONE; CELL MOTION; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GLYCOBIOLOGY; GLYCOSYLATION; HCT 116 CELL LINE; HEP-G2 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; REPRODUCIBILITY; WESTERN BLOTTING;

ACETYLGLUCOSAMINE; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CLONE CELLS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOMICS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HCT116 CELLS; HEP G2 CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRODUCIBILITY OF RESULTS;

EID: 84969662729     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.04.012     Document Type: Article

References (61)

1. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993, 363:558-561.
2. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819.
3. Duval A., Hamelin R. Genetic instability in human mismatch repair deficient cancers. Ann. Genet. 2002, 45:71-75.
4. Woerner S.M., Gebert J., Yuan Y.P., Sutter C., Ridder R., Bork P., von Knebel Doeberitz M. Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. Int. J. Cancer 2001, 93:12-19.
5. Woerner S.M., Benner A., Sutter C., Schiller M., Yuan Y.P., Keller G., Bork P., Doeberitz M.K., Gebert J.F. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 2003, 22:2226-2235.
6. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995, 268:1336-1338.
7. Grady W.M., Myeroff L.L., Swinler S.E., Rajput A., Thiagalingam S., Lutterbaugh J.D., Neumann A., Brattain M.G., Chang J., Kim S.J., Kinzler K.W., Vogelstein B., Willson J.K., Markowitz S. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 1999, 59:320-324.
8. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353.
9. Massague J. TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 2012, 13:616-630.
10. Du J., Hong S., Dong L., Cheng B., Lin L., Zhao B., Chen Y.G., Chen X. Dynamic sialylation in transforming growth factor-beta (TGF-beta)-induced epithelial to mesenchymal transition. J. Biol. Chem. 2015, 290:12000-12013.
11. Kurcon T., Liu Z., Paradkar A.V., Vaiana C.A., Koppolu S., Agrawal P., Mahal L.K. miRNA proxy approach reveals hidden functions of glycosylation. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:7327-7332.
12. Mackiewicz A., Kushner I. Transforming growth factor beta 1 influences glycosylation of alpha 1-protease inhibitor in human hepatoma cell lines. Inflammation 1990, 14:485-497.
13. Patsos G., André S., Roeckel N., Gromes R., Gebert J., Kopitz J., Gabius H.J. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 2009, 19:726-734.
14. Lee J., Ballikaya S., Schönig K., Ball C.R., Glimm H., Kopitz J., Gebert J. Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) colorectal cancer cell line HCT116. PLoS One 2013, 8.
15. Lee J., Warnken U., Schnolzer M., Gebert J., Kopitz J. A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target. Protein Sci. 2015, 24:1686-1694.
16. Park J.J., Lee M. Increasing the alpha 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver 2013, 7:629-641.
17. Gagneux P., Cheriyan M., Hurtado-Ziola N., van der Linden E.C., Anderson D., McClure H., Varki A., Varki N.M. Human-specific regulation of alpha 2-6-linked sialic acids. J. Biol. Chem. 2003, 278:48245-48250.
18. Shen Y., Tiralongo J., Kohla G., Schauer R. Regulation of silaic acid O-acetylation in human colon mucosa. Biol. Chem. 2004, 385:145-152.
19. Langereis M.A., Bakkers M.J., Deng L., Padler-Karavani V., Vervoort S.J., Hulswit R.J., van Vliet A.L., Gerwig G.J., de Poot S.A., Boot W., van Ederen A.M., Heesters B.A., van der Loos C.M., van Kuppeveld F.J., Yu H., Huizinga E.G., Chen X., Varki A., Kamerling J.P., de Groot R.J. Complexity and diversity of the mammalian sialome revealed by nidovirus virolectins. Cell Rep. 2015, 11:1966-1978.
20. Corfield A.P., Myerscough N., Warren B.F., Durdey P., Paraskeva C., Schauer R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconj. J. 1999, 16:307-317.
21. Komori T., Takemasa I., Higuchi H., Yamasaki M., Ikeda M., Yamamoto H., Ohue M., Nakamori S., Sekimoto M., Matsubara K., Monden M. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J. Exp. Clin. Cancer Res. 2004, 23:521-527.
22. Huang M.C., Chen H.Y., Huang H.C., Huang J., Liang J.T., Shen T.L., Lin N.Y., Ho C.C., Cho I.M., Hsu S.M. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene 2006, 25:3267-3276.
23. Reedijk M., Odorcic S., Zhang H., Chetty R., Tennert C., Dickson B.C., Lockwood G., Gallinger S., Egan S.E. Activation of Notch signaling in human colon adenocarcinoma. Int. J. Oncol. 2008, 33:1223-1229.
24. Bruckner K., Perez L., Clausen H., Cohen S. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000, 406:411-415.
25. Moloney D.J., Panin V.M., Johnston S.H., Chen J., Shao L., Wilson R., Wang Y., Stanley P., Irvine K.D., Haltiwanger R.S., Vogt T.F. Fringe is a glycosyltransferase that modifies Notch. Nature 2000, 406:369-375.
26. Haltiwanger R.S. Regulation of signal transduction pathways in development by glycosylation. Curr. Opin. Struct. Biol. 2002, 12:593-598.
27. Panin V.M., Papayannopoulos V., Wilson R., Irvine K.D. Fringe modulates Notch-ligand interactions. Nature 1997, 387:908-912.
28. Shao L., Moloney D.J., Haltiwanger R. Fringe modifies O-fucose on mouse Notch1 at epidermal growth factor-like repeats within the ligand-binding site and the Abruptex region. J. Biol. Chem. 2003, 278:7775-7782.
29. Huang R., Tang Q., You Q., Liu Z., Wang G., Chen Y., Sun Y., Muhammad S., Wang X. Disparity expression of Notch1 in benign and malignant colorectal diseases. PLoS One 2013, 8.
30. Zhang Y., Li B., Ji Z.Z., Zheng P.S. Notch1 regulates the growth of human colon cancers. Cancer 2010, 116:5207-5218.
31. Blokzijl A., Dahlqvist C., Reissmann E., Falk A., Moliner A., Lendahl U., Ibanez C.F. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 2003, 163:723-728.
32. Samon J.B., Champhekar A., Minter L.M., Telfer J.C., Miele L., Fauq A., Das P., Golde T.E., Osborne B.A. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 2008, 112:1813-1821.
33. Zhang S., Chung W.C., Xu K. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. Oncogene 2015, 10.1038/onc.2015.306.
34. Welman A., Barraclough J., Dive C. Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2. Nat. Protoc. 2006, 1:803-811.
35. Mueller B., Bovet M., Yin Y., Stichel D., Malz M., Gonzalez-Vallinas M., Middleton A., Ehemann V., Schmitt J., Muley T., Meister M., Herpel E., Singer S., Warth A., Schirmacher P., Drasdo D., Matthaeus F., Breuhahn K. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells. J. Pathol. 2015, 237:390-401.
36. Deshpande M., Papp S., Schaffer L., Pouyani T. All-trans retinoic acid is an effective inhibitor of hyaluronate synthesis in a human dermal equivalent. Arch. Dermatol. Res. 2014, 306:619-633.
37. Deshpande M., Papp S., Schaffer L., Pouyani T. Hydrocortisone and triiodothyronine regulate hyaluronate synthesis in a tissue-engineered human dermal equivalent through independent pathways. J. Biosci. Bioeng. 2015, 119:226-236.
38. Gouveia R., Schaffer L., Papp S., Grammel N., Kandzia S., Head S.R., Kleene R., Schachner M., Conradt H.S., Costa J. Expression of glycogenes in differentiating human NT2N neurons. Downregulation of fucosyltransferase 9 leads to decreased Lewis(x) levels and impaired neurite outgrowth. Biochim. Biophys. Acta 2012, 1820:2007-2019.
39. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., Mittmann M., Wang C., Kobayashi M., Horton H., Brown E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 1996, 14:1675-1680.
40. Pouyani T., Papp S., Schaffer L. Tissue-engineered fetal dermal matrices. In Vitro Cell. Dev. Biol. Anim. 2012, 48:493-506.
41. Li C., Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2001, 2. (Research0032).
42. Breitling R., Armengaud P., Amtmann A., Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004, 573:83-92.
43. Hong F., Breitling R., McEntee C.W., Wittner B.S., Nemhauser J.L., Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006, 22:2825-2827.
44. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
45. Comelli E.M., Head S.R., Gilmartin T., Whisenant T., Haslam S.M., North S.J., Wong N.K., Kudo T., Narimatsu H., Esko J.D., Drickamer K., Dell A., Paulson J.C. A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 2006, 16:117-131.
46. Lombard V., Golaconda Ramulu H., Drula E., Coutinho P.M., Henrissat B. The carbohydrate-active enzyme database (CAZy) in 2013. Nucleic Acids Res. 2014, 42:D490-D495.
47. Taylor P., Takeuchi H., Sheppard D., Chillakuri C., Lea S.M., Haltiwanger R.S., Handford P.A. Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:7290-7295.
48. Masuda S., Kumano K., Shimizu K., Imai Y., Kurokawa M., Ogawa S., Miyagishi M., Taira K., Hirai H., Chiba S. Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci. 2005, 96:274-282.
49. Niimi H., Pardali K., Vanlandewijck M., Heldin C.H., Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J. Cell Biol. 2007, 176:695-707.
50. Han L., Diehl A., Nguyen N.K., Korangath P., Teo W., Cho S., Kominsky S., Huso D.L., Feigenbaum L., Rein A., Argani P., Landberg G., Gessler M., Sukumar S. The Notch pathway inhibits TGFbeta signaling in breast cancer through HEYL-mediated crosstalk. Cancer Res. 2014, 74:6509-6518.
51. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.
52. Santaguida M., Schepers K., King B., Sabnis A.J., Forsberg E.C., Attema J.L., Braun B.S., Passegue E. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 2009, 15:341-352.
53. Wu E., Palmer N., Tian Z., Moseman A.P., Galdzicki M., Wang X., Berger B., Zhang H., Kohane I.S. Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. PLoS One 2008, 3.
54. Hsu S., Huang F., Friedman E. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J. Cell. Physiol. 1995, 165:239-245.
55. Leof E.B., Proper J.A., Goustin A.S., Shipley G.D., DiCorleto P.E., Moses H.L. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:2453-2457.
56. Cole S.E., Levorse J.M., Tilghman S.M., Vogt T.F. Clock regulatory elements control cyclic expression of Lunatic Fringe during somitogenesis. Dev. Cell 2002, 3:75-84.
57. Shifley E.T., Cole S.E. Lunatic Fringe protein processing by proprotein convertases may contribute to the short protein half-life in the segmentation clock. Biochim. Biophys. Acta 2008, 1783:2384-2390.
58. Pino M.S., Kikuchi H., Zeng M., Herraiz M.T., Sperduti I., Berger D., Park D.Y., Iafrate A.J., Zukerberg L.R., Chung D.C. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology 2010, 138:1406-1417.
59. Yuan R., Ke J., Sun L., He Z., Zou Y., He X., Chen Y., Wu X., Cai Z., Wang L., Wang J., Fan X., Wu X., Lan P. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer. Clin. Exp. Metastasis 2015, 32:169-179.
60. Xu K., Usary J., Kousis P.C., Prat A., Wang D.Y., Adams J.R., Wang W., Loch A.J., Deng T., Zhao W., Cardiff R.D., Yoon K., Gaiano N., Ling V., Beyene J., Zacksenhaus E., Gridley T., Leong W.L., Guidos C.J., Perou C.M., Egan S.E. Lunatic Fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 2012, 21:626-641.
61. Carulli A.J., Keeley T.M., Demitrack E.S., Chung J., Maillard I., Samuelson L.C. Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration. Dev. Biol. 2015, 402:98-108.